Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2190915 dose-ranging study in persistent asthma
2010-019095-70Phase 2Completed
- Sponsor
- GSK
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of fiboflapon in asthma and persistent asthma (7 arms), sponsored by GSK. Started May 2010; status: completed.
02
Drugs
fiboflapon
03
Conditions
asthmapersistent asthma
Beyond the preview
Go deeper on 2010-019095-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019095-70.